Biosimilars Global Market Report 2021 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography. It covers the historic period – 2015-2020, and the forecast period – 2021-2025, with additional forecasts for 2025-2030. The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
TBRC’s market report includes a chapter on the COVID-19 impact on the biosimilars industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it. With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected biosimilars market growth numbers from 2021-2030.
The global biosimilars market is expected to grow from .49 billion in 2020 to .05 billion in 2021 at a compound annual growth rate (CAGR) of 7.5%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The biosimilars market is expected to reach .13 billion in 2025 at a CAGR of 27%.
The Biosimilars Global Market Report 2020-30 by The Business Research Company evaluates biosimilars market size, growth rate, drivers, biosimilars industry trends, and major companies.
The biosimilars market segments in the report are: 1) By Drug Type: Monoclonal Antibody, Immunomodulators, Hematopoietic Agents, Granulocyte Colony-Stimulating Factor (G-CSF) 2) By Cancer Type: Breast Cancer, Colorectal Cancer, Blood Cancer, Neutropenia Cancer, Non-Small Cell Lung Cancer, Others 3) By Distribution Type: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
The table of contents in TBRC’s biosimilars market report includes: 1. Executive Summary 2. Biosimilars Market Characteristics 3. Biosimilars Market Trends And Strategies 4. Impact Of COVID-19 On Biosimilars 5. Biosimilars Market Size And Growth ….. 28. Biosimilars Pipeline Analysis 29. Key Mergers And Acquisitions In The Biosimilars Market 30. Biosimilars Market Future Outlook and Potential Analysis 31. Appendix
About The Business Research Company: The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology. It has offices in the UK, the US and India and a network of trained researchers in 20+ countries globally.
Contact Information: The Business Research Company Europe: +44 207 1930 708 Asia: +91 88972 63534 Americas: +1 315 623 0293 Email: info@tbrc.info
Like it? Share it!
About the Author
Meghana Joined: January 20th, 2021 Articles Posted: 449
